Park West Asset Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.8M | Sell |
1,799,081
-5,163
| -0.3% | -$56.9K | 1.5% | 31 |
|
|
2025
Q1 | $16.1M | Buy |
1,804,244
+11,256
| +0.6% | +$101K | 1.3% | 31 |
|
|
2024
Q4 | $16.9M | Sell |
1,792,988
-70,000
| -4% | -$659K | 1.36% | 30 |
|
|
2024
Q3 | $15M | Buy |
1,862,988
+162,988
| +10% | +$1.31M | 1.07% | 30 |
|
|
2024
Q2 | $14.4M | Buy |
1,700,000
+542,837
| +47% | +$4.6M | 1.06% | 31 |
|
|
2024
Q1 | $10.4M | Buy |
1,157,163
+257,163
| +29% | +$2.31M | 0.74% | 27 |
|
|
2023
Q4 | $10.1M | Sell |
900,000
-1,083,251
| -55% | -$12.2M | 0.99% | 28 |
|
|
2023
Q3 | $17.1M | Buy |
1,983,251
+262,500
| +15% | +$2.27M | 1.57% | 18 |
|
|
2023
Q2 | $17.8M | Sell |
1,720,751
-179,452
| -9% | -$1.86M | 1.56% | 18 |
|
|
2023
Q1 | $20.6M | Sell |
1,900,203
-20,121
| -1% | -$218K | 1.84% | 15 |
|
|
2022
Q4 | $21.5M | Buy |
1,920,324
+970
| +0.1% | +$10.9K | 2.11% | 14 |
|
|
2022
Q3 | $19.5M | Sell |
1,919,354
-1,253,900
| -40% | -$12.7M | 1.38% | 18 |
|
|
2022
Q2 | $28.8M | Buy |
3,173,254
+2,833,254
| +833% | +$25.7M | 1.63% | 18 |
|
|
2022
Q1 | $3.25M | Buy |
+340,000
| New | +$3.25M | 0.11% | 62 |
|